Alicia Jenkins is an endocrinologist and clinician researcher with an interest in the prediction and prevention of diabetes complications and the use of technology in diabetes care. She is affiliated with the Baker Heart and Diabetes Institute, University of Melbourne, Monash University and St. Vincent's Hospital Melbourne.

Dr Sarah Abdo is the Co-head of Department at Bankstown-Lidcombe Hospital Diabetes centre. She leads the Young Adult Clinic, a multidisciplinary service for young people with Diabetes as well as the Metabolic Health Clinic for patients with diabetes and obesity.

Dr. Jeffrey Cannon is an early career researcher specialising in global disease burden, health economics, childhood health, Indigenous health, equality, and policy. His research interests lie in generating timely information on the full health, economic, and social burdens of disease and in developing and applying traditional and new epidemiology and economic models to facilitate policy decisions. Dr Cannon earned a PhD in Health Economics from the University of Western Australia in 2019 and previously received an Honours degree in Mathematics after a BSc (Mathematics) and BBus (Finance) dual degree.

Dr. Huang is a senior research fellow in the Diabetes and Vascular Medicine Laboratory (Baker Heart and Diabetes Institute. He has produced 47 papers with >16000 citations in high-impact journals & 1 patent in novel therapeutics. His current research seeks to better predict and elucidate the development of diabetes complication.

Timothy Davis is an academic endocrinologist and general physician based at Fremantle Hospital. He is Principal Investigator of the Fremantle Diabetes Study, a community-based longitudinal observational study which has been running since 1993.

Professor Timothy Davis is a Professor of Medicine at the University of WA and a Consultant Physician at Fremantle and Fiona Stanley Hospitals. He has active clinical and research interests in diabetes/endocrinology. He has been principal investigator of the longitudinal observational Fremantle Diabetes Study since its inception in 1993.

David Chen is a cardiology trainee at Ryde Hospital, Sydney and a MPhil candidate at Baker Heart and Diabetes Institute. He has strong interests in cardiometabolic disease and is currently undertaking a MPhil looking at cardiometabolic outcomes and effects of adjunct glucose lowering therapies in adults with type 1 diabetes.

Dr Snaith is a Staff Specialist Endocrinologist and leads the young adult diabetes transition service at St Vincent’s Hospital, Sydney. In her PhD studies, she performed hyperinsulinaemic-euglycaemic clamps to measure muscle and liver insulin resistance in type 1 diabetes and determine the effect of metformin on insulin resistance in type 1 diabetes. She is involved with adjunctive therapies clinical trials in type 1 diabetes through the Garvan Institute, including the INTIMET study (metformin), RESET1 (semaglutide), TIRTLE (tirzepatide). Jen’s post-doctoral work is a supported by JDRF Australia.

Michelle So is a Clinical Research Fellow at St Vincent’s Institute and endocrinologist at Royal Melbourne and Northern Hospitals. She obtained her PhD in 2018 investigating C-peptide as a target of peripheral T-cells in type 1 diabetes. Michelle completed post-doctoral research in the area of type 1 diabetes prevention and translational immunology at the Diabetes Clinical Research Program at Benaroya Research Institute (Seattle, USA) in 2019-2020. Michelle is the education and training lead for the Australasian Type 1 Diabetes Immunotherapy Collaborative (ATIC).